2023 Q1 Form 10-Q Financial Statement

#000147793223001414 Filed on March 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q2 2021 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $2.357K $236.00
YoY Change -27.83% -79.39%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $28.55K $793.00
YoY Change -56.09% -78.68%
Operating Profit -$28.55K -$793.00
YoY Change -56.09% -78.68%
Interest Expense $2.946K $101.00
YoY Change -50.94% -97.45%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$31.49K
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$31.49K -$311.7M
YoY Change -99.99% 4061125.24%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 9.309M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q2 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.390K
YoY Change
Cash & Equivalents $7.386K $1.920K $2.132K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.386K $1.920K $2.132K
YoY Change 1410.43%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $7.386K $1.920K $2.132K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $7.386K $1.920K $2.132K
YoY Change 1410.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $58.69K $45.69K $7.861K
YoY Change -14.85%
Accrued Expenses $242.2K $244.3K $246.2K
YoY Change -1.12%
Deferred Revenue
YoY Change
Short-Term Debt $35.86K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $337.7K $315.3K $255.0K
YoY Change -0.03%
LONG-TERM LIABILITIES
Long-Term Debt $88.85K
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $88.85K $96.93K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $337.7K $315.3K $255.0K
Total Long-Term Liabilities $88.85K $96.93K
Total Liabilities $426.6K $408.7K $351.9K
YoY Change -1.4%
SHAREHOLDERS EQUITY
Retained Earnings -$9.815M -$9.772M -$9.716M
YoY Change -96.95%
Common Stock $4.931K $931.00 $108.00
YoY Change -85.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$419.2K -$406.8K -$349.8K
YoY Change
Total Liabilities & Shareholders Equity $7.386K $1.920K $2.132K
YoY Change 1410.43%

Cashflow Statement

Concept 2023 Q1 2022 Q2 2021 Q3
OPERATING ACTIVITIES
Net Income -$31.49K -$311.7M
YoY Change -99.99% 4061125.24%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$17.39K
YoY Change -99.99%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 24.63K
YoY Change -99.99%
NET CHANGE
Cash From Operating Activities -17.39K
Cash From Investing Activities
Cash From Financing Activities 24.63K
Net Change In Cash 7.240K
YoY Change -540.66%
FREE CASH FLOW
Cash From Operating Activities -$17.39K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001386044
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
710496 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1079116 shares
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54853
dei Entity Registrant Name
EntityRegistrantName
FREEDOM HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2560951
dei Entity Address Address Line1
EntityAddressAddressLine1
6461 N 100E
dei Entity Address City Or Town
EntityAddressCityOrTown
Ossian
dei Entity Address State Or Province
EntityAddressStateOrProvince
IN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
46777
dei City Area Code
CityAreaCode
260
dei Local Phone Number
LocalPhoneNumber
490-9990
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9308825 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1920 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
1920 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
2132 usd
CY2022Q2 us-gaap Assets
Assets
1920 usd
CY2021Q3 us-gaap Assets
Assets
2132 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
45688 usd
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7861 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
751 usd
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
922 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
244325 usd
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
246208 usd
CY2022Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
24530 usd
CY2021Q3 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
0 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
315294 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
254991 usd
CY2022Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
93404 usd
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
96933 usd
CY2022Q2 us-gaap Liabilities
Liabilities
408698 usd
CY2021Q3 us-gaap Liabilities
Liabilities
351924 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
71 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
931 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
108 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9364428 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9366161 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9772138 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9716132 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-406778 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-349792 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1920 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2132 usd
CY2022Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 usd
CY2021Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
9300 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
21900 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9300 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21900 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
0 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
557 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
2575 usd
us-gaap Professional Fees
ProfessionalFees
69427 usd
us-gaap Professional Fees
ProfessionalFees
2575 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
236 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1145 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4080 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1859 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
793 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
3720 usd
us-gaap Operating Expenses
OperatingExpenses
73507 usd
us-gaap Operating Expenses
OperatingExpenses
4434 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-793 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3720 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-73507 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4434 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
27000 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
27000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q2 fhld Gain Loss On Related Party Acquisition
GainLossOnRelatedPartyAcquisition
311672729 usd
CY2021Q2 fhld Gain Loss On Related Party Acquisition
GainLossOnRelatedPartyAcquisition
0 usd
fhld Gain Loss On Related Party Acquisition
GainLossOnRelatedPartyAcquisition
0 usd
fhld Gain Loss On Related Party Acquisition
GainLossOnRelatedPartyAcquisition
0 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
101 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
3955 usd
us-gaap Interest Expense
InterestExpense
9499 usd
us-gaap Interest Expense
InterestExpense
10049 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-311699037 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-7675 usd
us-gaap Net Income Loss
NetIncomeLoss
-56006 usd
CY2022Q2 fhld Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
1.02
CY2021Q2 fhld Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.01
fhld Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.00
fhld Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.01
CY2022Q2 fhld Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
304106332 shares
CY2021Q2 fhld Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
1077582 shares
fhld Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
211286080 shares
fhld Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
1077582 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-121714 usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
31400 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-259478 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-349792 usd
fhld Converted Preferred Stock Into Common Amount
ConvertedPreferredStockIntoCommonAmount
0 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-980 usd
us-gaap Net Income Loss
NetIncomeLoss
-56006 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-406778 usd
us-gaap Net Income Loss
NetIncomeLoss
-56006 usd
us-gaap Net Income Loss
NetIncomeLoss
-14483 usd
fhld Increase Decrease In Accounts Payable And Accruals
IncreaseDecreaseInAccountsPayableAndAccruals
35945 usd
fhld Increase Decrease In Accounts Payable And Accruals
IncreaseDecreaseInAccountsPayableAndAccruals
-3930 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-171 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20232 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18413 usd
fhld Proceeds From Paidin Capital Related Party
ProceedsFromPaidinCapitalRelatedParty
0 usd
fhld Proceeds From Paidin Capital Related Party
ProceedsFromPaidinCapitalRelatedParty
21899 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-3530 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-3450 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
24530 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 usd
fhld Payments Of Cancellation Of Common Stock
PaymentsOfCancellationOfCommonStock
980 usd
fhld Payments Of Cancellation Of Common Stock
PaymentsOfCancellationOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20020 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18449 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-212 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2132 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1920 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
55 usd
us-gaap Interest Paid Net
InterestPaidNet
9499 usd
us-gaap Interest Paid Net
InterestPaidNet
10049 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash. </p>
CY2022Q2 us-gaap Cash
Cash
1920 usd
CY2021Q3 us-gaap Cash
Cash
2132 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9772138 usd
us-gaap Net Income Loss
NetIncomeLoss
-56006 usd
CY2017Q3 us-gaap Unsecured Debt
UnsecuredDebt
50000 usd
CY2017Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.15 pure
us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
750 usd
CY2022Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
93404 usd
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
96933 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
751 usd
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
922 usd
CY2022Q2 fhld Note Payable And Accrued Interest
NotePayableAndAccruedInterest
94155 usd
CY2021Q3 fhld Note Payable And Accrued Interest
NotePayableAndAccruedInterest
97855 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
244325 usd
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
246208 usd
CY2021Q4 fhld Preferred Stock Description
PreferredStockDescription
On December 30, 2021, the Company converted all of the 710,676 shares of issued and outstanding preferred stock consisting of Series A, B,C and D preferred stock, into 15,920,945 shares of common stock
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
710496 shares
CY2021Q4 us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
1 pure
CY2021Q4 fhld Share Exchange For Common Stock
ShareExchangeForCommonStock
311672730 shares
CY2021Q4 fhld Share Exchange For Common Stock Per Share
ShareExchangeForCommonStockPerShare
1.00
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9308825 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1079116 shares

Files In Submission

Name View Source Status
0001477932-23-001414-index-headers.html Edgar Link pending
0001477932-23-001414-index.html Edgar Link pending
0001477932-23-001414.txt Edgar Link pending
0001477932-23-001414-xbrl.zip Edgar Link pending
fhld-20220630.xsd Edgar Link pending
fhld_10q.htm Edgar Link pending
fhld_ex311.htm Edgar Link pending
fhld_ex312.htm Edgar Link pending
fhld_ex321.htm Edgar Link pending
fhld_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fhld-20220630_cal.xml Edgar Link unprocessable
fhld-20220630_def.xml Edgar Link unprocessable
fhld-20220630_lab.xml Edgar Link unprocessable
fhld-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
fhld_10q_htm.xml Edgar Link completed